Skip to main content
logo
KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.9000
+0.0013 (0.14%)
Aug 19, 2026, 4:00 PM EDT - Market closed

KALA BIO Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----3.8911.24
Revenue Growth
-----65.37%76.67%
Gross Profit
----1.337.14
Operating Income
-24.41-42.41-40.43-39.15-81.36-109.43
Net Income
-10.08-26.98-38.51-42.2-44.82-142.61
Earnings Per Share
-1.30-165.56-507.25-867.58-1474.00-5416.07
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
7.237.5651.1850.970.593.05
Total Debt
--32.2536.3242.9580.19
Net Cash (Debt)
7.237.5618.9314.5727.5512.86
Net Cash Growth
259.29%-60.08%29.90%-47.10%114.21%-75.84%
Net Cash Per Share
0.9346.37249.32299.59905.73488.38

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-19.86-31.99-29.38-27.93-78.91-108.24
Capital Expenditures
-0.02-0.02-0.21-0.61-0.31-0.89
Free Cash Flow
-19.88-32.01-29.59-28.54-79.22-109.12
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----34.22%63.55%
Operating Margin
-----2090.34%-973.60%
Pretax Margin
-----1151.64%-1268.73%
Profit Margin
-----1151.64%-1268.73%
FCF Margin
-----2035.48%-970.83%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-0.610.610.610.61-
PS Ratio
----15.647.05